Zimmer Biomet Holdings Inc (NYSE:ZBH)
$ 103.88 0.28 (0.27%) Market Cap: 21.16 Bil Enterprise Value: 26.51 Bil PE Ratio: 21.64 PB Ratio: 1.67 GF Score: 78/100

Q1 2024 Zimmer Biomet Holdings Inc Earnings Call Transcript

May 02, 2024 / 12:30PM GMT
Release Date Price: $118.46 (-0.92%)

Key Points

Positve
  • Zimmer Biomet Holdings Inc (ZBH) reported Q1 performance ahead of expectations with 4.4% constant currency revenue growth.
  • The company reaffirmed its full-year guidance, projecting 5% to 6% constant currency revenue growth and mid- to high single-digit adjusted earnings growth.
  • Zimmer Biomet Holdings Inc (ZBH) saw strong adoption of ROSA technology and Persona Knee, contributing significantly to the quarter's success.
  • The company has made significant progress in its strategic priorities, including operational excellence and innovation, with over 40 new products planned for release in the next 24 to 36 months.
  • Zimmer Biomet Holdings Inc (ZBH) is experiencing healthy end markets driven by demographic shifts and technological advancements, supporting sustained demand.
Negative
  • Despite positive growth, the company faces challenges with pricing dynamics, although they have improved to about flat compared to historical erosion.
  • Zimmer Biomet Holdings Inc (ZBH) is still in the process of implementing its restructuring program, which could pose risks if not executed smoothly.
  • The company's effective tax rate increased by over 200 basis points, which could impact net earnings if it continues to rise.
  • Zimmer Biomet Holdings Inc (ZBH) reported a reliance on new product introductions for future growth, which could be risky if these products do not perform as expected.
  • There are ongoing competitive pressures in the orthopedics market, particularly in the robotics and joint replacement segments, which could impact market share and profitability.
Operator

Good morning, ladies and gentlemen, and welcome to the Zimmer Biomet First Quarter 2024 Earnings Conference Call. (Operator Instructions). As a reminder, this conference is being recorded today, May 2, 2024. Following today's presentation, there will be a question-and-answer session. (Operator Instructions).

I would now like to turn the conference over to Keri Mattox, Chief Communications and Administration Officer. Please go ahead.

Keri P. Mattox
Zimmer Biomet Holdings, Inc. - SVP and Chief Communications & Administration Officer

Thank you, operator, and good morning, everyone. Welcome to Zimmer Biomet's First Quarter 2024 Earnings Conference Call. Joining me today are Ivan Tornos, our President and CEO; and CFO and EVP Finance, Operations and Supply Chain, Suky Upadhyay.

Before we get started, I'd like to remind you that our comments during this call will include forward-looking statements. Actual results may differ materially from those indicated by the forward-looking statements due to a variety of risks and uncertainties. Please

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot